ZA200801151B - Solvate of cabergoline and preparations of cabergoline Form 1 - Google Patents

Solvate of cabergoline and preparations of cabergoline Form 1

Info

Publication number
ZA200801151B
ZA200801151B ZA200801151A ZA200801151A ZA200801151B ZA 200801151 B ZA200801151 B ZA 200801151B ZA 200801151 A ZA200801151 A ZA 200801151A ZA 200801151 A ZA200801151 A ZA 200801151A ZA 200801151 B ZA200801151 B ZA 200801151B
Authority
ZA
South Africa
Prior art keywords
cabergoline
solvate
preparations
cabergoline form
Prior art date
Application number
ZA200801151A
Inventor
Greenwood Alan Kenneth
Mchattie Derek
Bhatarah Parveen
Aloui Mahmoud
Original Assignee
Resolution Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Chemicals Ltd filed Critical Resolution Chemicals Ltd
Publication of ZA200801151B publication Critical patent/ZA200801151B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
ZA200801151A 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline Form 1 ZA200801151B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0515430.7A GB0515430D0 (en) 2005-07-27 2005-07-27 Preparation of cabergoline

Publications (1)

Publication Number Publication Date
ZA200801151B true ZA200801151B (en) 2009-04-29

Family

ID=34976701

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801151A ZA200801151B (en) 2005-07-27 2006-07-27 Solvate of cabergoline and preparations of cabergoline Form 1

Country Status (10)

Country Link
EP (1) EP1912984A1 (en)
JP (1) JP2009502895A (en)
CN (1) CN101228159A (en)
AU (1) AU2006273831A1 (en)
CA (1) CA2616738A1 (en)
GB (1) GB0515430D0 (en)
IL (1) IL188598A0 (en)
NO (1) NO20080461L (en)
WO (1) WO2007012846A1 (en)
ZA (1) ZA200801151B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925616A1 (en) * 2006-10-26 2008-05-28 LEK Pharmaceuticals D.D. Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline
CN104147041B (en) * 2014-08-17 2017-02-22 山西振东安特生物制药有限公司 Dispersion preparation containing colloidal bismuth pectin and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007308D0 (en) * 2000-03-24 2000-05-17 Pharmacia & Upjohn Spa Process for preparing crystalline form | of cabergoline
JP2005520831A (en) * 2002-03-15 2005-07-14 ファルマシア・コーポレーション Method for producing crystalline form I of cabergoline
IL163520A0 (en) * 2002-03-15 2005-12-18 Pharmacia Italia Spa Process for preparing crystalline form i of cabergoline
CA2525104A1 (en) * 2003-05-08 2004-11-25 Ivax Pharmaceuticals S.R.O. Polymorphs of cabergoline

Also Published As

Publication number Publication date
GB0515430D0 (en) 2005-08-31
IL188598A0 (en) 2008-04-13
JP2009502895A (en) 2009-01-29
CN101228159A (en) 2008-07-23
CA2616738A1 (en) 2007-02-01
WO2007012846A1 (en) 2007-02-01
AU2006273831A1 (en) 2007-02-01
NO20080461L (en) 2008-04-18
EP1912984A1 (en) 2008-04-23

Similar Documents

Publication Publication Date Title
IL172647A0 (en) Compositions of lipopeptide antibiotic derivatives and methods of use thereof
EP1879659A4 (en) Low-irritation compositions and methods of making the same
IL189364A0 (en) Estrogen compositions and therapeutic methods of use thereof
IL189795A0 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
IL218357A0 (en) Compositions and methods of using angiopoietin-like 4 protein
EP1851335A4 (en) Compositions and methods of use of standardized mixtures
GB0422525D0 (en) Dermatological compositions and methods
EP1812031A4 (en) Compositions and methods for modification of biomolecules
GB0411940D0 (en) Methods and compositions
EP1827362A4 (en) Compositions and methods of their use for improving the condition and appearance of skin
EP1838291A4 (en) Pharmaceutical formulations and methods of use
EP1701725A4 (en) Methods and compositions
IL190885A0 (en) Immunogenic compositions and methods of use
IL219406A0 (en) Antiloading compositions and methods of selecting same
IL191072A0 (en) Therapeutic compositions and methods
IL188223A0 (en) Formulations of conjugated estrogens and bazedoxifene
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
EP1946007A4 (en) Anbrosteeone derivatives and method of use thereof
EP1625141A4 (en) Grp94-based compositions and methods of use thereof
IL155545A0 (en) Novel solvate form of cabergoline and uses thereof
ZA200801151B (en) Solvate of cabergoline and preparations of cabergoline Form 1
EP1810976A4 (en) Benzonaphthaceneglycoside derivative and use thereof
IL186277A0 (en) Dnt-maleate and methods of preparation thereof
EP1898956A4 (en) Anti-tumoral compositions and methods
GB2392202B (en) Assembly of movable and lockable parts